Health Condition 1: L638- Other alopecia areata
Conditions
Interventions
Intervention1: Majoon-e-Chobchini, Microneedling: Microneedling and Majoon-e- chobchini will be given for the duration of 10 weeks.
Microneedling include needles, characterized by their micron-sized s
Sponsors
Ajmal khan tibbiya college and hospital Department of Amraz e jild wa zohrawiya
Eligibility
Inclusion criteria
Inclusion criteria: 1-Clinically diagnosed cases of Alopecia areata. [characterized by patchy, non-scarring hairloss with smooth scalp surface on inspection,presence of exclamation mark hairs on tricoscopy, History of associated Autoimmune -condition(s). 2-Clinically stable patients. 3-Patients of either gender. 4-Patients between 18-60 Years of age. 5-Patient not on any concomitant therapy. 6-Patient who has left the treatment at least 2 months back. 7-Patient willing to sign the written consent proforma. 8-Patient who follows the protocol.
Exclusion criteria
Exclusion criteria: 1-Subjects below 18 years and above 60 years. 2-Subjects with a known history of any autoimmune disorders. 3-K/C/O diabetes, bleeding disorder or patient on anticoagulant and /or antiplatelet therapy. 4-Subjects who had received either Anti-androgenic medications or drugs causing hypertrichosis or hypotrichosis, use of Ritlecitinib or other JAK inhibitors or topical minoxidil within 01 months prior to enrolment. 5-Subjects with surgical correction of scalp hair loss (hair transplant or scalp reduction). 6-Subjects with a known history of Seborrheic dermatitis, Lichen planopilaris, Scalp psoriasis, Tinea Capitis, Male androgenic alopecia, Alopecia Totalis,A.universalis, scarring alopecia Trichotillomania . 7-Subjects who fail to comply the study protocol or stop treatment midway during protocol will not be included in final data analysis but they will be reported separately.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A)Severity of Alopecia Tool (SALT) score B)Trichoscopy C)Alopecia Areata symptom impact scale (AASIS) D)Photographs of lesionTimepoint: At 15th, 30th, 45th, 60th, 75th day. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dermatology Life Quality of LifeTimepoint: At 15th, 30th, 45th, 60th, 75th day. | — |
Countries
India
Contacts
Public ContactDr Shabnam Jahan
Ajmal khan tibbiya college
Outcome results
None listed